Microglia and mast cells: Two tracks on the road to neuroinflammation

FASEB Journal

Volumn 26, Issue 8, 2012, Pages 3103-3117

  Skaper, Stephen D ^a   Giusti, Pietro ^a   Facci, Laura ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Endocannabinoids; Inflammation; Innate immunity; Macrophages; Neurodegeneration; Neuroimmune interactions; Pain

Indexed keywords

CELL COMMUNICATION; CELL FUNCTION; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; MAST CELL; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYMPTOM;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS; MICROGLIA; NEURODEGENERATIVE DISEASES; NEUROGLIA; PAIN; RECEPTORS, PURINERGIC; SPINAL CORD;

EID: 84864765533     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.11-197194     Document Type: Review

References (241)

1. Raghavendra, V., and DeLeo, J. A. (2004) The role of astrocytes and microglia in persistent pain. Adv. Mol. Cell Biol. 31, 951-966
2. Milligan, E. D., Maier, S. F., and Watkins, L. R. (2003) Review: Neuronal-glial interactions in central sensitization. Sem. Pain Med. 1, 171-183 (Pubitemid 40418221)
3. Najjar, S., Pearlman, D., Miller, D. C., and Devinsky, O. (2011) Refractory epilepsy associated with microglial activation. Neurologist 17, 249-254
4. Sailasuta, N., Harris, K., Tran, T., and Ross, B. (2011) Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study. Neuropsychiatr. Dis. Treat. 7, 495-499
5. Prat, A., Behrendt, M., Marcinkiewicz, E., Boridy, S., Sairam, R. M., Seidah, N. G., and Maysinger, D. (2011) A novel mouse model of Alzheimer's disease with chronic estrogen deficiency leads to glial cell activation and hypertrophy. J. Aging Res. 2011, 251517
6. Song, M., Jin, J., Lim, J. E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H. D., Tahara, K., Lalonde, R., and Fukuchi, K. (2011) TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J. Neuroinflammation 8, 92
7. Cho, S. H., Sun, B., Zhou, Y., Kauppinen, T. M., Halabisky, B., Wes, P., Ransohoff, R. M., and Gan, L. (2011) CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 286, 32713-32722
8. Fellner, L., Jellinger, K. A., Wenning, G. K., and Stefanova, N. (2011) Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts. Acta Neuropathol. 121, 675-693
9. Barcia, C., Ros, C.M., Annese, V., Gómez, A., Ros-Bernal, F., Aguado-Yera, D., Martínez-Pagán, M.E., de Pablos, V., Fernandez-Villalba, E., and Herrero, M. T. (2011) IFN-α signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis. 2, e142
10. Appel, S. H., Zhao, W., Beers, D. R., and Henkel, J. S. (2011) The microglial-motoneuron dialogue in ALS. Acta Myol. 30, 4-8
11. Mitterauer, B. J. (2011) Possible role of glia in cognitive impairment in schizophrenia. CNS Neurosci. Ther. 17, 333-344
12. Hinwood, M., Morandini, J., Day, T. A., and Walker, F. R. (2011) Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. [E-pub ahead of print] Cereb. Cortex doi: 10.1093/cercor/bhr229
13. Gao, Y. J., and Ji, R. R. (2010) Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol. Ther. 126, 56-68
14. Zhuo, M., Wu, G., and Wu, L. J. (2011) Neuronal and microglial mechanisms of neuropathic pain. Mol. Brain 4, 31
15. Nakagawa, T., and Kaneko, S. (2010) Spinal astrocytes as therapeutic targets for neuropathic pain. J. Pharmacol. Sci. 114, 347-353
16. 7 receptors as a transducer in the co-occurrence of neurological/psychiatric and cardiovascular aisorders: a hypothesis. Cardiovasc. Psychiatry Neurol. 2009, 545263
17. Rivat, C., Becker, C., Blugeot, A., Zeau, B., Mauborgne, A., Pohl, M., and Benoliel, J. J. (2010) Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain 150, 358-368
18. Vichaya, E. G., Young, E. E., Frazier, M. A., Cook, J. L., Welsh, C. J., and Meagher, M. W. (2011) Social disruption induced priming of CNS inflammatory response to Theiler's virus is dependent upon stress induced IL-6 release. J. Neuroimmunol. 239, 44-52
19. Rodewald, H. R., Dessing, M., Dvorak, A. M., and Galli, S. J. (1996) Identification of a committed precursor for the mast cell lineage. Science 271, 818-822 (Pubitemid 26058936)
20. Chen, C. C., Grimbaldeston, M. A., Tsai, M., Weissman, I. L., and Galli, S. J. (2005) Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. U. S. A. 102, 11408-11413 (Pubitemid 41153833)
21. Galli, S. J., Nakae, S., and Tsai, M. (2005) Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135-142 (Pubitemid 40268194)
22. Gilfillan, A. M., Austin, S. J., and Metcalfe, D. D. (2011) Mast cell biology: introduction and overview. Adv. Exp. Med. Biol. 716, 2-12
23. Lambracht-Hall, M., Dimitriadou, V., and Theoharides, T. C. (1990) Migration of mast cells in the developing rat brain. Dev. Brain. Res. 56, 151-159 (Pubitemid 20364123)
24. Silverman, A. J., Sutherland, A. K., Wilhelm, M., and Silver, R. (2000) Mast cells migrate from blood to brain. J. Neurosci. 20, 401-408 (Pubitemid 30220526)
25. Engler, H., Doenlen, R., Engler, A., Riether, C., Prager, G., Niemi, M. B., Pacheco-López, G., Krügel, U., and Schedlowski, M. (2011) Acute amygdaloid response to systemic inflammation. Brain Behav. Immun. 25, 1384-1392
26. Moreno, B., Jukes, J. P., Vergara-Irigaray, N., Errea, O., Villoslada, P., Perry, V. H., and Newman, T. A. (2011) Systemic inflammation induces axon injury during brain inflammation. Ann. Neurol. 70, 932-942
27. Johnson, D., and Krenger, W. (1992) Interactions of mast cells with the nervous system - recent advances. Neurochem. Res. 17, 939-951
28. Gauchat, J. F., Henchoz, S., Mazzei, G., Aubry, J. P., Brunner, T., Blasey, H., Life, P., Talabot, D., Flores-Romo, L., Thompson, J., Kishi, K., Butterfield, J., Dahinden, C., and Bonnefoy, J.-Y. (1993) Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340-343 (Pubitemid 23288974)
29. Wardlaw, A. J., Moqbel, R., Cromwell, O., and Kay, A. B. (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest. 78, 1701-1706 (Pubitemid 17219536)
30. Perry, V. H., Andersson, P.-B., and Gordon, G. (1993) Macrophages and inflammation in the central nervous system. Trends Neurosci. 16, 268-273 (Pubitemid 23168847)
31. Johnson, D., Yasui, D., and Seeldayers, P. (1991) An analysis of mast cell frequency in the rodent nervous system: numbers vary between different strains and can be reconstituted in mast cell-deficient mice. J. Neuropathol. Exp. Neurol. 50, 227-234
32. Brenner, T., Soffer, D., Shalit, M., and Levi-Schaffer, F. (1994) Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122, 210-213 (Pubitemid 24097271)
33. Theoharides, T. C. (1990) Mast cells: the immune gate to the brain. Life Sci. 46, 607-617
34. Rozniecki, J. J., Hauser, S. L., Stein, M., Lincoln, R., and Theoharides, T. C. (1995) Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37, 63-66
35. Medic, N., Vita, F., Abbate, R., Soranzo, M. R., Pacor, S., Fabbretti, E., Borelli, V., and Zabucchi, G. (2008) Mast cell activation by myelin through scavenger receptor. J. Neuroimmunol. 200, 27-40
36. Niederhoffer, N., Levy, R., Sick, E., Andre, P., Coupin, G., Lombard, Y., and Gies, J. P. (2009) Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses. Int. J. Immunopathol. Pharmacol. 22, 473-483
37. Theoharides, T. C., Baloyannis, S. J., and Manolidis, L. S. (1991) Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int. J. Immunopathol. Pharmacol. 4, 137-144
38. Medic, N., Lorenzon, P., Vita, F., Trevisan, E., Marchioli, A., Soranzo, M. R., Fabbretti, E., and Zabucchi, G. (2010) Mast cell adhesion induces cytoskeletal modifications and programmed cell death in oligodendrocytes. J. Neuroimmunol. 218, 57-66
39. Nautiyal, K. M., Ribeiro, A. C., Pfaff, D. W., and Silver, R. (2008) Brain mast cells link the immune system to anxiety-like behavior. Proc. Natl. Acad. Sci. U. S. A. 105, 18053-18057
40. Woolf, C. J., and Salter, M. W. (2000) Neuronal plasticity: increasing the gain in pain. Science 288, 1765-1769
41. DeLeo, J. A., and Yezierski, R. P. (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90, 1-6 (Pubitemid 32146552)
42. Watkins, L. R., Milligan, E. D., and Maier, S. F. (2001) Spinal cord glia: new players in pain. Pain 93, 201-205 (Pubitemid 32763176)
43. Watkins, L. R., Milligan, E. D., and Maier, S. F. (2003) Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv. Exp. Med. Biol. 521, 1-21 (Pubitemid 36535161)
44. Wei, F., Dubner, R., and Ren, K. (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J. Neurosci. 27, 6006-6018 (Pubitemid 46849761)
45. Burnstock, G., Krügel, U., Abbracchio, M. P., Illes, P. (2011) Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229-274
46. Tozaki-Saitoh, H., Tsuda, M., Miyata, H., Ueda, K., Kohsaka, S., and Inoue, K. (2008) P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 28, 4949-4956
47. Ballini, E., Virginio, C., Medhurst, S. J., Summerfield, S. G., Aldegheri, L., Buson, A., Carignani, C., Chen, Y. H., Giacometti, A., Lago, I., Powell, A. J., and Jarolimek, W. (2011) Characterization of three diaminopyrimidines as potent and selective antagonists of P2X3 and P2X2/3 receptors with in vivo efficacy in a pain model. Br. J. Pharmacol. 163, 1315-1325
48. 4 expression and initiates neuropathic pain development. EMBO J. 30, 1864-1873
49. 7 receptors. Neuroscience 192, 721-731
50. Inoue, K., and Tsuda, M. (2012) Purinergic systems, neuropathic pain and the role of microglia. Exp. Neurol. 234, 293-301
51. 12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 28, 2892-2902
52. 7purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114, 386-396
53. 4 receptors in acute and chronic pain assays. Mol. Pain 5, 28
54. Skaper, S. D. (2011) Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol. Disord. Drug Targets 10, 44-56
55. Ji, R. R., Gereau, R. W. 4th, Malcangio, M., and Strichartz, G. R. (2009) MAP kinase and pain. Brain Res. Rev. 60, 135-148
56. Crown, E. D., Gwak, Y. S., Ye, Z., Johnson, K. M., and Hulsebosch, C. E. (2008) Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury. Exp. Neurol. 213, 257-267
57. Lee, M. K., Han, S. R., Park, M. K., Kim, M. J., Bae, Y. C., Kim, S. K., Park, J. S., and Ahn, D. K. (2011) Behavioral evidence for the differential regulation of p-p38 MAPK and p-NF-κB in rats with trigeminal neuropathic pain. Mol. Pain 7, 57
58. Maier, S. F. (2003) Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain Behav. Immun. 17, 69-85
59. Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., and Maier, S. F. (2007) Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 2, 47-59 (Pubitemid 44854445)
60. Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., Day, T. A., and Walker, F. R. (2010) Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 24, 1058-1068
61. McNamee, E. N., Griffin, E. W., Ryan, K. M., Ryan, K. J., Heffernan, S., Harkin, A., and Connor, T. J. (2010) Noradrenaline acting at β-adrenoceptors induces expression of IL-1βand its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology 59, 37-48
62. Cole, S. W., Arevalo, J. M., Takahashi, R., Sloan, E. K., Lutgendorf, S. K., Sood, A. K., Sheridan, J. F., and Seeman, T. E. (2010) Computational identification of gene-social environment interaction at the human IL-6 locus. Proc. Natl. Acad. Sci. U. S. A. 107, 5681-5686
63. Wohleb, E. S., Hanke, M. L., Corona, A. W., Powell, N. D., Stiner, L. M., Bailey, M. T., Nelson, R. J., Godbout, J. P., and Sheridan, J. F. (2011) β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31, 6277-6288
64. Smith, J.A., Das, A., Ray, S. K., and Banik, N. L. (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res. Bull. 87, 10-20
65. Lull, M. E., and Block, M. L. (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics 7, 354-365
66. Galli, S. J., Kalesnikoff, J., Grimbaldeston, A., Piliponsky, A., Williams, C., and Tsai, M. (2005) Mast cells are "tunable"effector and immunoregulatory cells: Recent advances. Ann. Rev. Immunol. 23, 749-786 (Pubitemid 40563184)
67. Silver, R., Silverman, A., Vitkovic, L., and Lederhendler, I. (1996) Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19, 25-31 (Pubitemid 26011580)
68. Khalil, M., Silverman, A., and Silver, R. (2003) Mast cells in the rat brain synthesize gonadotropin-releasing hormone. J. Neurobiol. 56, 113-124 (Pubitemid 36870449)
69. Michaloudi, H., Grivas, I., Batzios, C., Chiotelli, M., and Papadopoulos, G. (2003) Parallel development of blood vessels and mast cells in the lateral geniculate nuclei. Brain Res. Develop. Brain Res. 140, 269-276 (Pubitemid 36173983)
70. Zlokovic, B. V. (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat. Rev. Neurosci. 12, 723-738
71. Del Zoppo, G. J. (2009) Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 158, 972-982
72. Bona, E., Andersson, A. L., Blomgren, K., Gilland, E., Puka-Sundvall, M., Gustafson, K., and Hagberg, H. (1999) Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr. Res. 45, 500-509 (Pubitemid 29162729)
73. Griffiths, M. R., Gasque, P., and Neal, J. W. (2009) The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. Neuropathol. Exp. Neurol. 68, 217-226
74. Jin, Y., Silverman, A. J., and Vannucci, S. J. (2009) Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40, 3107-3112
75. Chew, L. J., Takanohashi, A., and Bell, M. (2006) Microglia and inflammation: impact on developmental brain injuries. Ment. Retard. Dev. Disabil. Res. Rev. 12, 105-112
76. Gordon, J. R., and Galli, S. J. (1991) Release of both preformed and newly synthesized tumor necrosis factor-α (TNF-α)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-αduring IgE-dependent biological responses. J. Exp. Med. 174, 103-107
77. Cocchiara, R., Bongiovanni, A., Albeggiani, G., Lampiasi, N., and Geraci, D. (1997) Substance P selectively activates TNF-αproduction in rat uterine immune cells: a neuroimmune link. Neuroreport 8, 2961-2964 (Pubitemid 27394827)
78. Gregersen, R., Lambertsen, K., and Finsen, B. (2000) Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 20, 53-65 (Pubitemid 30019830)
79. Lambertsen, K. L., Meldgaard, M., Ladeby, R., and Finsen, B. (2005) A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 25, 119-135 (Pubitemid 40096903)
80. Hallenbeck, J. M. (2002) The many faces of tumor necrosis factor in stroke. Nat. Med. 8, 1363-1368
81. Jin, Y., Silverman, A. J., and Vannucci, S. J. (2007) Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev. Neurosci. 29, 373-384 (Pubitemid 47343691)
82. Strbian, D., Karjalainen-Lindsberg, M. L., Tatlisumak, T., and Lindsberg, P. J. (2006) Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J. Cereb. Blood Flow Metab. 26, 605-612
83. Strbian, D., Karjalainen-Lindsberg, M. L., Kovanen, P. T., Tatlisumak, T., and Lindsberg, P. J. (2007) Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation 116, 411-418 (Pubitemid 47196546)
84. Biran, V., Cochois, V., Karroubi, A., Arrang, J. M., Charriaut-Marlangue, C., and Heron, A. (2008) Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain. Brain Pathol. 18, 1-9
85. Lozada, A., Maegele, M., Stark, H., Neugebauer, E. M., and Panula, P. (2005) Traumatic brain injury results in mast cell increase and changes in regulation of central histamine receptors. Neuropathol. Appl. Neurobiol. 31, 150-162 (Pubitemid 40444916)
86. Lindsberg, P. J., Strbian, D., and Karjalainen-Lindsberg, M. L. (2010) Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J. Cereb. Blood Flow Metab. 30, 689-702
87. Tchougounova, E., Lundequist, A., Fajardo, I., Winberg, J. O., Abrink, M., and Pejler, G. (2005) A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J. Biol. Chem. 280, 9291-9296 (Pubitemid 40409621)
88. Mattila, O. S., Strbian, D., Saksi, J., Pikkarainen, T. O., Rantanen, V., Tatlisumak, T., and Lindsberg, P. J. (2011) Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke 42, 3600-3605
89. Henkel, J. S., Beers, D. R., Wen, S., Bowser, R., and Appel, S. H. (2009) Decreased mRNA expression of tight junction proteins in lumbar spinal cords of patients with ALS. Neurology 72, 1614-1616
90. Alvarez, J. I., Cayrol, R., and Prat, A. (2011) Disruption of central nervous system barriers in multiple sclerosis. Biochim. Biophys. Acta 1812, 252-264
91. Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., and Zlokovic, B. V. (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427
92. Fiala, M., Chattopadhay, M., La Cava, A., Tse, E., Liu, G., Lourenco, E., Eskin, A., Liu, P. T., Magpantay, L., Tse, S., Mahanian, M., Weitzman, R., Tong, J., Nguyen, C., Cho, T., Koo, P., Sayre, J., Martinez-Maza, O., Rosenthal, M. J., and Wiedau-Pazos, M. (2010) IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients. Neuroinflammation 7, 76
93. Graves, M. C., Fiala, M., Dinglasan, L. A., Liu, N. Q., Sayre, J., Chiappelli, F., van Kooten, C., and Vinters, H. V. (2004) Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 5, 213-219 (Pubitemid 40125187)
94. Sayed, B. A., Walker, M. E., and Brown, M. A. (2011) Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J. Immunol. 186, 3294-3298
95. Piette, F., Belmin, J., Vincent, H., Schmidt, N., Pariel, S., Verny, M., Marquis, C., Mely, J., Hugonot-Diener, L., Kinet, J. P., Dubreuil, P., Moussy, A., and Hermine, O. (2011) Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res. Ther. 3, 16
96. Esposito, P., Gheorghe, D., Kandere, K., Pang, X., Connolly, R., Jacobson, S., and Theoharides, T. C. (2001) Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888, 117-127 (Pubitemid 32056268)
97. Xanthos, D.N., Gaderer, S., Drdla, R., Nuro, E., Abramova, A., Ellmeier, W., and Sandkühler, J. (2011) Central nervous system mast cells in peripheral inflammatory nociception. Mol. Pain 7, 42
98. Zuo, Y., Perkins, N. M., Tracey, D. J., and Geczy, C. L. (2003) Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 105, 467-479 (Pubitemid 37186908)
99. Levy, D., Kainz, V., Burstein, R., and Strassman, A. M. (2012) Mast cell degranulation distinctly activates trigemino-cervical and lumbosacral pain pathways and elicits widespread tactile pain hypersensitivity. Brain Behav. Immun. 26, 311-317
100. Koda, H., and Mizumura, K. (2002) Sensitization to mechanical stimulation by inflammatory mediators and by mild burn in canine visceral nociceptors in vitro. J. Neurophysiol. 87, 2043-2051 (Pubitemid 34670766)
101. Jankowski, M. P., and Koerber, H. R. (2010) Translational pain research: from mouse to man. In Frontiers in Neuroscience (Kruger, L., and Light, A. R., eds) chap. 2, CRC Press, Boca Raton, FL, USA
102. Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanello, S., Aloe, L., and Levi-Montalcini, R. (1994) Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 91, 3739-3743 (Pubitemid 24139507)
103. Levi-Montalcini, R., Skaper, S. D., Dal Toso, R., Petrelli, L., and Leon, A. (1996) Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci. 19, 514-520 (Pubitemid 26359871)
104. Vallières, L., and Rivest, S. (1997) Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1β. J. Neurochem. 69, 1668-1683 (Pubitemid 27406968)
105. Leal-Berumen, I., Conlon, P., and Marshall, J. S. (1994) IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152, 5468-5476 (Pubitemid 24152996)
106. Folgueras, A. R., Valdés-Sánchez, T., Llano, E., Menéndez, L., Baamonde, A., Denlinger, B. L., Belmonte, C., Juárez, L., Lastra, A., García-Suárez, O., Astudillo, A., Kirstein, M., Pendás, A. M., Fariñas, I., and López- Otín, C. (2009) Metalloproteinase MT5-MMP is an essential modulator of neuroimmune interactions in thermal pain stimulation. Proc. Natl. Acad. Sci. U. S. A. 106, 16451-16456
107. Suzuki, A., Suzuki, R., Furuno, T., Teshima, R., and Nakanishi, M. (2004) N-cadherin plays a role in the synapse-like structures between mast cells and neuritis. Biol. Pharm. Bull. 27, 1891-1894 (Pubitemid 41701560)
108. Hayashi, R., Xiao, W., Kawamato, M., Yuge, O., and Bennett, G. J. (2011) Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFα)-positive mast cells in rats with a painful peripheral neuropathy. J. Pharmacol. Sci. 106, 559-565 (Pubitemid 351556233)
109. Wood, J. D. (2011) Visceral pain: spinal afferents, enteric mast cells, enteric nervous system and stress. Curr. Pharm. Des. 17, 1573-1575
110. Done, J. D., Rudick, C. N., Quick, M. L., Schaeffer, A. J., and Thumbikat, P. (2012) Role of mast cells in male chronic pelvic pain. J. Urol. 187, 1473-1482
111. Sand, E., Themner-Persson, A., and Ekblad, E. (2009) Mast cells reduce survival of myenteric neurons in culture. Neuropharmacology 56, 522-530
112. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011) Physiology of microglia. Physiol. Rev. 91, 461-553
113. Hanisch, U.-K., and Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394 (Pubitemid 350014685)
114. Kim, S. U., and de Vellis, J. (2005) Microglia in health and disease. J. Neurosci. Res. 81, 302-313 (Pubitemid 41359284)
115. Huitinga, I., van Rooijen, N. de Groot, C. J. A., Uitdehaag, B. M. J., and Dijkstra, C. D. (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1033 (Pubitemid 20343201)
116. Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., Becher, B., and Aguzzi, A. (2005) Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (Pubitemid 40321349)
117. Kotter, M. R., Zhao, C., van Rooijen, N., and Franklin, R. J. M. (2005) Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol. Dis. 18, 166-175 (Pubitemid 40092906)
118. Stadelmann, C., Kerschensteiner, M., Misgeld, T., Brück, W., Hohlfeld, R., and Lassmann, H. (2002) BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125, 75-85 (Pubitemid 34084038)
119. Filbin, M. T. (2003) Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4, 703-713
120. Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., and Boddeke, H. W. (2012) Identification of a microglia phenotype supportive of remyelination. Glia 60, 306-321
121. Derecki, N.C., Cronk, J.C., Lu, Z., Xu, E., Abbott, S.B.G., Guyenet, P. G., and Kipnis, J. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109
122. Wyss-Coray, T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015
123. El Khoury, J., and Luster, A. D. (2008) Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications. Trends Pharmacol. Sci. 29, 626-632
124. Zotova, E., Nicoll, J.A., Kalaria, R., Holmes, C., and Boche, D. (2010) Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimer's Res. Ther. 2, 1
125. Martín-Moreno, A. M., Reigada, D., Ramírez, B. G., Mechoulam, R., Innamorato, N., Cuadrado, A., and de Ceballos, M. L. (2011) Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Mol. Pharmacol. 79, 964-973
126. Fan, R., Xu, F., Previti, M. L., Davis, J., Grande, A. M., Robinson, J. K., and Van Nostrand, W. E. (2007) Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J. Neurosci. 27, 3057-3063 (Pubitemid 46474134)
127. Nathan, C., Calingasan, N., Nezezon, J., Ding, A., Lucia, M. S., La Perle, K., Fuortes, M., Lin, M., Ehrt, S., Kwon, N. S., Chen, J., Vodovotz, Y., Kipiani, K., and Beal, M. F. (2005) Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J. Exp. Med. 202, 1163-1169 (Pubitemid 41586946)
128. Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., Aguzzi, A., Staufenbiel, M., Mathews, P. M., Wolburg, H., Heppner, F. L., and Jucker, M. (2009) Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia. Nat. Neurosci. 12, 1361-1363
129. Meyer-Leuhmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht- Talboo, J., Holtzman, D. M., Bacskai, B. J., and Hyman, B. T. (2008) Rapid appearance and local toxicity of amyloid-βplaques in a mouse model of Alzheimer's disease. Nature 451, 720-724 (Pubitemid 351220570)
130. Town, T., Laouar, Y., Pittenger, C., Mori, T., Szekely, C. A., Tan, J., Duman, R. S., and Flavell, R. A. (2008) Blocking TGF-β-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat. Med. 14, 681-687 (Pubitemid 351809551)
131. Takata, K., Kitamura, Y., Yanagisawa, D., Morikawa, S., Morita, M., Inubushi, T., Tsuchiya, D., Chishiro, S., Saeki, M., Taniguchi, T., Shimohama, S., and Tooyama, I. (2007) Microglial transplantation increases amyloid-β clearance in Alzheimer model rats. FEBS Lett. 581, 475-478 (Pubitemid 46149623)
132. El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., and Luster, A. D. (2007) Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer- like disease. Nat. Med. 13, 432-438 (Pubitemid 46559828)
133. Wang, Q., Tang, X. N., and Yenari, M. A. (2007) The inflammatory response in stroke. J. Neuroimmunol. 184, 53-68 (Pubitemid 46365991)
134. Dheen, S. T., Kaur, C., and Ling, E. A. (2007) Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 14, 1189-1197 (Pubitemid 46739320)
135. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., and Kriz, J. (2007) Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596-2605 (Pubitemid 46393607)
136. Imai, F., Suzuki, H., Oda, J., Ninomiya, T., Ono, K., Sano, H., and Sawada, M. (2007) Neuroprotective effect of exogenous microglia in global brain ischemia. J. Cereb. Blood Flow Metab. 27, 488-500
137. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318 (Pubitemid 40746128)
138. Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., and Nabekura, J. (2009) Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974-3980
139. Vinet, J., van Weering, H. R., Heinrich, A., Kälin, R. E., Wegner, A., Brouwer, N., Heppner, F. L., van Rooijen, N., Boddeke, H. W., and Biber, K. (2012) Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J. Neuroinflammation 9, 27
140. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., and Gan, W. B. (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758 (Pubitemid 43085841)
141. 12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512-1519
142. Trapp, B. D., Wujek, J. R., Criste, G. A., Jalabi, W., Yin, X., Kidd, G. J., Stohlman, S., and Ransohoff, R. (2007) Evidence for synaptic stripping by cortical microglia. Glia 55, 360-368
143. Rappert, A., Bechmann, I., Pivneva, T., Mahlo, J., Biber, K., Nolte, C., Kovac, A. D., Gerard, C., Boddeke, H. W., Nitsch, R., and Kettenmann, H. (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 24, 8500-8509 (Pubitemid 39313773)
144. Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., Botti, P., Bacon, K. B., and Feng, L. (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 95, 10896-10901 (Pubitemid 28413165)
145. Ransohoff, R. M., and Perry, V. H. (2009) Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145
146. Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Alves Ferreira, T., Guiducci, E., Dumas, L.,
147. Tremblay, M.E., Lowery, R. L., and Majewska, A. K. (2010) Microglial interactions with synapses are modulated by visual experience. PLoS Biol. 8, e1000527
148. Schafer, D. P., Lehrman, E. K., Kautzman, A. K., Koyama, R., Mardinly, A. R., Barres, B. A., and Stevens, B. (2011) Microglia shape neural circuits in the developing brain. Soc. Neuosci. Abstr. 37, 663.03
149. Lazarini, F., Gabellec, M.-M., Torquet, N., and Lledo, P. M. (2012) Early activation of microglia triggers long-lasting impairment of adult neurogenesis in the olfactory bulb. J. Neurosci. 32, 3652-3664
150. Secor, V. H., Secor, W. E., Gutekunst, C. A., and Brown, M. A. (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191, 813-822
151. Tanzola, M. B., Robbie-Ryan, M., Gutekunst, C. A., and Brown, M. A. (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171, 4385-4391 (Pubitemid 37238717)
152. Bennett, J. L., Blanchet, M. R., Zhao, L., Zbytnuik, L., Antignano, F., Gold, M., Kubes, P., and McNagny, K. M. (2009) Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J. Immunol. 182, 5507-5514
153. Adams, R. A., Schachtrup, C., Davalos, D., Tsigelny, I., and Akassoglou, K. (2007) Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis. Curr. Med. Chem. 14, 2925-2936 (Pubitemid 350201659)
154. Kulka, M., Fukuishi, N., and Metcalfe, D. D. (2009) Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily. J. Leukoc. Biol. 86, 1217-1226
155. Gellera, C., Colombrita, C., Ticozzi, N., Castellotti, B., Bragato, C., Ratti, A., Taroni, F., and Silani, V. (2008) Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics 9, 33-40
156. Schymick, J. C., Talbot, K., and Traynor, B. J. (2007) Genetics of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 16, R233-R242
157. Subramanian, V., Crabtree, B., and Acharya, K. R. (2008) Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum. Mol. Genet. 17, 130-149
158. Echtenacher, B., Mannel, D. N., and Hultner, L. (1996) Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77 (Pubitemid 26130005)
159. Trautmann, A., Toksoy, A., Engelhardt, E., Brocker, E. B., and Gillitzer, R. (2000) Mast cell involvement in normal human skin wound healing: expression of monocyte chemoattractant protein-1 is correlated with recruitment of mast cells which synthesize interleukin-4 in vivo. J. Pathol. 190, 100-106 (Pubitemid 30053360)
160. Noli, C., and Miolo, A. (2001) The mast cell in wound healing. Vet. Dermatol. 12, 303-313 (Pubitemid 33686158)
161. Weller, K., Foitzik, K., Paus, R., Syska, W., and Maurer, M. (2006) Mast cells are required for normal healing of skin wounds in mice. FASEB J. 20, 2366-2368
162. Younan, G. J., Heit, Y. I., Dastouri, P., Kekhia, H., Xing, W., Gurish, M. F., and Orgill, D. P. (2011) Mast cells are required in the proliferation and remodeling phases of microdeformational wound therapy. Plast. Reconstr. Surg. 128, 649e-658e
163. Okun, E., Griffioen, K. J., and Mattson, M. P. (2011) Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 34, 269-281
164. Trinchieri, G., and Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190
165. Tanga, F. Y., Nutile-McMenemy, N., and DeLeo, J. A. (2005) The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A. 102, 5856-5861 (Pubitemid 40559649)
166. Kim, D., Kim, M. A., Cho, I.-H., Kim, M. S., Lee, S., Jo, E.-K., Choi, S. Y., Park, K., Kim, J. S., Akira, S., Na, H. S., Oh, S. B., and Lee, S. J. (2007) A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 282, 14975-14983 (Pubitemid 47093373)
167. Shi, X. Q., Zekki, H., and Zhang, J. (2011) The role of TLR2 in nerve injury-induced neuropathic pain is essentially mediated through macrophages in peripheral inflammatory response. Glia 59, 231-241
168. Nicotra L., Loram L. C., Watkins, L. R., and Hutchinson, M. R. (2012) Toll-like receptors in chronic pain. Exp. Neurol. 234, 316-329
169. Kono, H., and Rock, K. L. (2008) How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (Pubitemid 351432799)
170. Okamura, Y., Watari, M., Jerud, E. S., Young, D. W., Ishizaka, S. T., Rose, J., Chow, J. C., and Strauss, J. F. (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276, 10229-10233
171. Asea, A., Rehli, M., Kabingu, E., Boch, J. A., Bare, O., Auron, P. E., Stevenson, M. A., and Calderwood, S. K. (2002) Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol. Chem. 277, 15028-15034 (Pubitemid 34952579)
172. Piccinini, A. M., and Midwood, K. S. (2010) DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010, pii: 672395
173. McCurdy, J. D., Olynych, T. J., Maher, L. H., and Marshall, J. S. (2003) Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 170, 1625-1629 (Pubitemid 36197374)
174. Lin, S., Zhong, Q., Lv, F. L., Zhou, Y., Li, J. Q., Wang, J. Z., Yang, Q. W., and Yin, Q. (2012) Heme activates TLR4-mediated inflammatory injury via MyD88/TRIF signaling pathway in intracerebral hemorrhage. J. Neuroinflammation 9, 46
175. Obata, K., Katsura, H., Miyoshi, K., Kondo, T., Yamanaka, H., Kobayashi, K., Dai, Y., Fukuoka, T., Akira, S., and Noguchi, K. (2008) Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J. Neurochem. 105, 2249-2259 (Pubitemid 351782279)
176. Varadaradjalou, S., Féger, F., Thieblemont, N., Hamouda, N. B., Pleau, J. M., Dy, M., and Arock, M. (2003) Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol. 33, 899-906 (Pubitemid 36546677)
177. Kulka, M., Alexopoulou, L., Flavell, R. A., and Metcalfe, D. D. (2004) Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114, 174-182 (Pubitemid 39005135)
178. Orinska, Z., Bulanova, E., Budagian, V., Metz, M., Maurer, M., and Bulfone-Paus, S. (2005) TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106, 978-987 (Pubitemid 41076443)
179. Ribes, S., Adam, N., Ebert, S., Regen, T., Bunkowski, S., Hanisch, U. K., and Nau, R. (2010) The viral TLR3 agonist poly(I: C) stimulates phagocytosis and intracellular killing of Escherichia coli by microglial cells. Neurosci. Lett. 482, 17-20
180. Feuser, K., Thon, K.P., Bischoff, S. C., and Lorentz, A. (2012) Human intestinal mast cells are a potent source of multiple chemokines. Cytokine 58, 178-185
181. Skuljec, J., Sun, H., Pul, R., Bénardais, K., Ragancokova, D., Moharregh-Khiabani, D., Kotsiari, A., Trebst, C., and Stangel, M. (2011) CCL5 induces a pro-inflammatory profile in microglia in vitro. Cell. Immunol. 270, 164-171
182. Pietrzak, A., Wierzbicki, M., Wiktorska, M., and Brzezińska- Błaszczyk, E. (2011) Surface TLR2 and TLR4 expression on mature rat mast cells can be affected by some bacterial components and proinflammatory cytokines. Mediators Inflamm. 2011, 427473
183. Hamanaka, J., and Hara, H. (2011) Involvement of Toll-like receptors in ischemia-induced neuronal damage. Cent. Nerv. Syst. Agents Med. Chem. 11, 107-113
184. Buchanan, M. M., Hutchinson, M., Watkins, L. R., and Yin, H. (2010) Toll-like receptor 4 in CNS pathologies. J. Neurochem. 114, 13-27
185. Liu, S., Liu, Y., Hao, W., Wolf, L., Kiliaan, A. J., Penke, B., Rübe, C. E., Walter, J., Heneka, M. T., Hartmann, T., Menger, M. D., and Fassbender, K. (2012) TLR2 is a primary receptor for Alzheimer's amyloid β peptide to trigger neuroinflammatory activation. J. Immunol. 188, 1098-1107
186. 2 receptor-mediated signaling in mast cell biology. Purinergic Signal. 6, 3-17
187. Osipchuk, Y., and Cahalan, M. (1992) Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359, 241-244
188. Chakraborty, S., Kaushik, D. K., Gupta, M., and Basu, A. (2010) Inflammasome signaling at the heart of central nervous system pathology. J. Neurosci. Res. 88, 1615-1631
189. Ulmann, L., Hatcher, J. P., Hughes, J. P., Chaumont, S., Green, P. J., Conquet, F., Buell, G. N., Reeve, A. J., Chessell, I. P., and Rassenden, F. (2008) Up-regulation of P2X4 receptors on spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 28, 11263-11268
190. 4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 29, 3518-3528
191. Yuan, H., Zhu, X., Zhou, S., Chen, Q., Zhu, X., Ma, X., He, X., Tian, M., and Shi, X. (2010) Role of mast cell activation in inducing microglial cells to release neurotrophin. J. Neurosci. Res. 88, 1348-1354
192. Zhang, X. C., and Levy, D. (2008) Modulation of meningeal nociceptors mechanosensitivity by peripheral proteinase-activated receptor-2: the role of mast cells. Cephalalgia 28, 276-284
193. Zhang, H., Lin, L., Yang, H., Zhang, Z., Yang, X., Zhang, L., and He, S. (2010) Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6. Cytokine 50, 138-145
194. Zhang, H., Yang, H., and He, S. (2010) TNF increases expression of IL-4 and PARs in mast cells. Cell. Physiol. Biochem. 26, 327-336
195. Juremalm, M., Hjertson, M., Olsson, N., Harvima, I., Nilsson, K., and Nilsson, G. (2000) The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur. J. Immunol. 30, 3614-3622 (Pubitemid 32005235)
196. Lin, T. J., Issekutz, T. B., and Marshall, J. S. (2001) SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells. Int. Arch. Allergy Immunol. 12, 142-145 (Pubitemid 32304786)
197. Põlajeva, J., Sjösten, A.M., Lager, N., Kastemar, M., Waern, I., Alafuzoff, I., Smits, A., Westermark, B., Pejler, G., Uhrbom, L., and Tchougounova, E. (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS One 6, e25222
198. Wang, X., Li, C., Chen, Y., Hao, Y., Zhou, W., Chen, C., and Yu, Z. (2008) Hypoxia enhances CXCR4 expression favoring microglia migration via HIF-1α activation. Biochem. Biophys. Res. Commun. 371, 283-288
199. Lu, D. Y., Tang, C. H., Yeh, W. L., Wong, K. L., Lin, C. P., Chen, Y. H., Lai, C. H., Chen, Y. F., Leung, Y. M., and Fu, W. M. (2009) SDF-1α up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-κB-dependent pathway in microglia. Eur. J. Pharmacol. 613, 146-154
200. Wang, Y., Huang, J., Li, Y., and Yang, G. Y. (2012) Roles of chemokine CXCL12 and its receptors in ischemic stroke. Curr. Drug Targets 13, 166-172
201. Bhangoo, S. K., Ren, D., Miller, R. J., Chan, D. M., Ripsch, M. S., Weiss, C., McGinnis, C., and White, F. A. (2007) CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy. Brain Behav. Immun. 21, 581-591 (Pubitemid 46829778)
202. Knerlich-Lukoschus, F., von der Ropp-Brenner, B., Lucius, R., Mehdorn, H. M., and Held-Feindt, J. (2011) Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain. J. Neurosurg. Spine 14, 583-597
203. Klos, A., Tenner, A. J., Johswuch, K.-O., Ager, R. R., and Köhl, J. (2009) The role of the anaphylatoxins in health and disease. Mol. Immunol. 46, 2753-2766
204. Gasque, P., Singhrao, S. K., Neal, J. W., Götze, O., and Morgan, B. P. (1997) Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150, 31-41 (Pubitemid 27027093)
205. Griffin, R. S., Costigan, M., Brenner, G. J., Ma, C. H., Scholz, J., Moss, A., Allchorne, A. J., Stahl, G. L., and Woolf, C. J. (2007) Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity. J. Neurosci. 27, 8699-8708 (Pubitemid 47254273)
206. Soruri, A., Grigat, J., Kiafard, Z., and Zwirner, J. (2008) Mast cell activation is characterized by upregulation of a functional anaphylatoxin C5a receptor. BMC Immunol. 9, 29
207. Zhang, X., Kimura, Y., Fang, C., Zhou, L., Sfyroera, G., Lambris, J. D., Wetsel, R. A., Miwa, T., and Song, W. C. (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228-236 (Pubitemid 47026839)
208. Seeldrayers, P. A., Levin, L. A., and Johnson, D. (1992) Astrocytes support mast cell viability in vitro. J. Neuroimmunol. 36, 239-243
209. Kim, D. Y., Jeoung, D., and Ro, J. Y. (2010) Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J. Immunol. 185, 273-283
210. Hösli, L., Hösli, E., Schneider, U., and Wiget, W. (1984) Evidence for the existence of histamine H1- and H2-receptors on astrocytes of cultured rat central nervous system. Neurosci. Lett. 48, 287-291 (Pubitemid 14054437)
211. Kim, D.Y., Hong, G. U., and Ro, J. Y. (2011) Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J. Neuroinflammation 8, 25
212. Gosselin, R. D., Suter, M. R., Ji, R. R., and Decosterd, I. (2010) Glial cells and chronic pain. Neuroscientist 16, 519-531
213. Mika, J. (2008) Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine tolerance. Pharmacol. Rep. 60, 297-307
214. Thacker, M. A., Clark, A. K., Marchand, F., McMahon, S. B. (2007) Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth. Analg. 105, 838-847 (Pubitemid 47300869)
215. Avigen Inc. (2006) AV333 (Chronic Neuropathic Pain). http://www.avigen. com/av333.php
216. Suk, K., and Ock, J. (2011) Chemical genetics of neuroinflammation: natural and synthetic compounds as microglial inhibitors. [E-pub ahead of print] Inflammopharmacology. doi: 10.1007/s10787-011-0108-2
217. Oliveira, S. M., Drewes, C. C., Silva, C. R., Trevisan, G., Boschen, S. L., Moreira, C. G., de Almeida Cabrini, D., Da Cunha, C., and Ferreira, J. (2011) Involvement of mast cells in a mouse model of postoperative pain. Eur. J. Pharmacol. 672, 88-95
218. Ralay Ranaivo, H., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Van Eldik, L. J., Watterson, D. M. (2006) Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J. Neurosci. 26, 662-670 (Pubitemid 43237131)
219. Chico, L. K., Van Eldik, L. J., and Watterson, D. M. (2009) Targeting protein kinases in central nervous system disorders. Nat. Rev. Drug Disc. 8, 892-909
220. Gaestel, M., and Kotlyarov, A. (2012) Small-molecule protein and lipid kinase inhibitors in inflammation and specific models for their evaluation. Methods Mol. Biol. 795, 35-44
221. Burguillos, M. A., Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B. (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472, 319-324
222. Hutchinson, M. R., Zhang, Y., Shridhar, M., Evans, J. H., Buchanan, M. M., Zhao, T. X., Slivka, P. F., Coats, B. D., Rezvani, N., Wieseler, J., Hughes, T. S., Landgraf, K. E., Chan, S., Fong, S., Phipps, S., Falke, J. J., Leinwand, L. A., Maier, S. F., Yin, H., Rice, K. C., and Watkins, L. R. (2010) Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 24, 83-95
223. Zhang, H., Chang, M., Hansen, C. N., Basso, D. M., and Noble-Haeusslein, L. J. (2011) Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury. Neurotherapeutics 8, 206-220
224. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305 (Pubitemid 38220550)
225. Muccioli, G. G., Stella, N. (2008) Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 54, 16-22 (Pubitemid 350299394)
226. Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., and Leon, A. (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U. S. A. 92, 3376-3380
227. Cerrato, S., Brazis, P., della Valle, M. F., Miolo, A., and Puigdemont, A. (2010) Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cells. Vet. Immunol. Immunopathol. 133, 9-15
228. Franklin, A., Parmentier-Batteur, S., Walter, L., Greenberg, D. A., and Stella, N. (2003) Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J. Neurosci. 23, 7767-7775 (Pubitemid 37052344)
229. Berger, C., Schmid, P. C., Schabitz, W. R., Wolf, M., Schwab, S., and Schmid, H. H. (2004) Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J. Neurochem. 88, 1159-1167 (Pubitemid 38280683)
230. Schäbitz, W. R., Giuffrida, A., Berger, C., Aschoff, A., Schwaninger, M., Schwab, S., and Piomelli, D. (2002) Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33, 2112-2114 (Pubitemid 34840078)
231. Costa, B., Conti, S., Giagnoni, G., and Colleoni, M. (2002) Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems. Br. J. Pharmacol. 137, 413-420 (Pubitemid 35221894)
232. 1, TRPV1 and PPARγ receptors and neurotrophic factors. Pain 139, 541-550
233. D'Agostino, G., La Rana, G., Russo, R., Sasso, O., Iacono, A., Esposito, E., Mattace Raso, G., Cuzzocrea, S., Loverme, J., Piomelli, D., Meli, R., and Calignano, A. (2009) Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-κB nuclear signalling in dorsal root ganglia. Eur. J. Pharmacol. 613, 54-59
234. De Filippis, D., Luongo, L., Cipriano, M., Palazzo, E., Cinelli, M.P., de Novellis, V., Maione, S., and Iuvone, T. (2011) Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats. Mol. Pain 7, 3
235. Esposito, E., Paterniti, I., Mazzon, E., Genovese, T., Di Paola, R., Galuppo, M., and Cuzzocrea, S. (2011) Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain. Behav. Immun. 25, 1099-112
236. Skaper, S. D., Facci, L., Romanello, S., and Leon, A. (1996) Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J. Neurochem. 66, 1157-1166 (Pubitemid 26068390)
237. Skaper, S. D., Buriani, A., Dal Toso, R., Petrelli, L., Romanello, S., Facci, L., and Leon, A. (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl. Acad. Sci. U. S. A. 93, 3984-3989 (Pubitemid 26146721)
238. Truini, A., Biasiotta, A., Di Stefano, G., La Cesa, S., Leone, C., Cartoni, C., Federico, V., Petrucci, M., and Cruccu, G. (2011) Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy. CNS Neurol. Disord. Drug Targets 10, 916-920
239. Kopsky, D. J., and Hesselink, J. M. (2012) Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain. Acupunct. Med. 30, 53-55
240. David, S., and Kroner, A. (2011) Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399
241. Schäfer, T., Starkl, P., Allard, C., Wolf, R. M., and Schweighoffer, T. (2010) A granular variant of CD63 is a regulator of repeated human mast cell degranulation. Allergy 65, 1242-1255